Document is current
Any future updates will be listed below
-
Authors
Heckl, Steffen M.
Behrens, Hans-Michael
Ebert, Ulrike
Ulase, Dita
Richter, Florian
Becker, Thomas
Letsch, Anne
Röcken, Christoph https://orcid.org/0000-0002-6989-8002
-
Funding
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
- License Information
-
More Information
Article History
Received: 10 February 2025
Accepted: 5 May 2025
First Online: 16 May 2025
Declarations
:
: AL received payment or honoraria from Astra Zeneca, Bayer, BMS, Böhringer Ingelheim, Grünenthal, Janssen, Lilly, MSD, Novartis, Roche, Servier and Tesaro. AL participates on the advisory boards of MSD, BMS and Lilly. AL has a leadership role in the Board of Directors European Association of Palliative Care (2023–2026) and in the ESMO Supportive and Palliative Care Faculty (2023–2026). All other authors declare no competing interests.
: All procedures followed were in accordance with the ethical standards of the ethics committee [D453/10 (22.10.2010); D525/15 (20.08.2015)] of the University Hospital Schleswig–Holstein, Kiel, Germany, which allowed us to use samples from those patients who had also given written informed consent for prospective scientific use of their patient material (broad consent). The study was performed in compliance with all relevant laws and institutional guidelines and in accordance with the code of ethics of the Helsinki Declaration of 1964 and later versions.
